Cannabis and Hemp Industry Investment News
's () Dr Sean Hall tells Proactive's Andrew Scott they're focused on achieving regulatory approval for its lead drug candidate NanaBis™ in the shortes...
The combination of two formulations, Mg Optima Relax and CBD, promote relaxation and reduces stress. The first order of 5,000 units has been manufactu...
A share purchase plan is also underway with proceeds from both activities to smooth the path of the company’s NanaBis™ to Phase 3 trials submissions. ...
The company’s newest cannabinoid formulation treats patients with chemotherapy-induced nausea and vomiting (CINV). NanoCBD will undergo clinical trial...
TASALK is a world-leading fully integrated manufacturer and exporter of controlled substance extracts, including medicinal opiates and cannabis produc...
The company has several catalysts signifying progression to watch for. This progression is important as it serves as a stepping-stone to its goal - ne...
The University of Sydney has validated Medlab’s NanoCelle™ Chloroquine (CQ) nanoparticle characteristics. Medlab’s core focus remains across the chron...
An announcement is pending in relation to an extension of Medlab’s NanoCelle™ platform to anti-malaria drugs. A trading halt has been granted until Ap...
's () Dr Sean Hall caught up with Proactive's Andrew Scott after signing a Heads of Agreement (HoA) with Randall Communications Pty Ltd - trading as F...
The company is developing therapies for pain management, depression and obesity as well as earning revenue from the sale of nutritional products in Au...
The medical life science company received a government grant of $75,000 for the clinical depression trial, which was conducted at the Queensland Unive...
Medlab has developed the virtual clinic so that anyone can have access to a free, no-obligation, 10-minute confidential consultation via any computer ...
The strong results allow Medlab to focus on phase three designs specifically in the patient group with metastatic bone pain where breast or prostate a...
The NanaBis™ study seeks to recruit 2,000 Australian patients via medical or hospital settings to provide intervention data over a 12-month period. Me...
The company is developing cannabis-based medicines like NanaBis™ for pain management and is focussed on securing a pathway to drug registration and ma...
The agreement results in manufacturing of the patented cannabis-based medicine being transferred to Tasmanian Alkaloids. NanaBis is poised for a major...
Medlab is a revenue generating research company with an aggressive product development pipeline. The number of NanaBis™ and NanaBidial™ cannabis bottl...
What does Medlab Clinical do? () is a cannabis drug developer and nutraceutical products manufacturer based in Australia. The seven-year-old New South...
Placement funds will help the company address short-term goals as it prepares for Phase 3 research of the NanaBis™ drug candidate program. The placeme...
The company’s securities will remain halted until Tuesday, December 17 or when an announcement is released to the market. Medlab is developing therapi...
